A Celsius Network co-founder has moved in court to declare the entirety of his equity stake in the embattled crypto company as “worthless.” In a Monday document to the United States Bankruptcy Court, law firm Kirkland & Ellis LLP filed a declaration on behalf of Celsius Co-Founder Daniel Leon, confirming his status as a substantial shareholder and declaring that his 32,600 common shares are now considered worthless. #CelsiusNetwork #CelsiusBankruptcy Here’s a new one — a declaration of “wothlessness” was just filed by Daniel Leon , one of the cofounders. The Declaration was filed by K&E. https://t.co/OHldovdhBZ — David Adler (@DavidJAdler1991) September 5, 2022 A declaration that a particular stock or common share is “worthless” generally occurs when shareholders in a company...
A report by the World Bank has noted that over the past 12 months, the Covid-19 pandemic has harmed the poor and vulnerable the most, and it is threatening to push millions more into poverty. This year, the World Bank said, after decades of steady progress in reducing the number of people living on less than $1.90/day, COVID-19 will usher in the first reversal in the fight against extreme poverty in a generation. The report said the latest analysis warns that COVID-19 has pushed an additional 88 million people into extreme poverty this year – and that figure is just a baseline. “In a worst-case scenario, the figure could be as high as 115 million. The World Bank Group forecasts that the largest share of the ‘new poor will be in South Asia, with Sub-Saharan Africa close behind. ddAccording ...
Human trials began on Thursday for Nanocovax, Vietnam’s first home-grown COVID-19 vaccine, a Director of a National Medical Research Centre said. “In the first phase, we will choose a group of 60 volunteers. This morning, we have finished vaccinating three people. “They will be monitored for three days, and if they remain in good condition, we will continue to vaccinate the rest.’’ Ho Anh Son, Deputy Director of the Military Medical Research Institute, told dpa. The trial is the first of three phases of testing for the vaccine. The second phase will involve testing on between 400 and 600 volunteers, according to the Health Ministry’s reports. Researchers told local media that an independent monitoring organisation will be hired to ensure the safety of volunteer participants and guarantee t...